Types of Cancer We Treat

Ovarian Cancer

Our gynecologic oncologists diagnose ovarian cancer and treat it using the latest surgical procedures, including minimally invasive, robotic-assisted, and fertility-sparing approaches and clinical trials.

Our gynecologic oncologists, genetic counselors, and fertility specialists offer services for women at an increased genetic risk of developing ovarian cancer. Our experts help you carefully consider whether screening or risk-reduction surgery is right for you.

We understand how important quick decisions are in treating ovarian cancer, so we generally see you within 48 hours of your appointment request. We complement cancer care with support services, including integrative health therapies, psychological support, genetic testing, and survivorship plans.

Find a Doctor & Schedule
Diagnosis
Surgery
Fertility-Sparing Procedures
Chemotherapy & Targeted Drugs

Related News

Oncologist Discusses Gynecologic Cancer Trends & Treatments
Read Story
Robust Clinical Trials for Gynecologic Cancer Save Lives
Read Story
Cancer Immunotherapies Provide People Better Quality of Life
Read Story
Surgical Oncologist Advances Treatment for Women’s Cancers
Read Story
Breast Cancer Previvor Discusses Genetic Testing
Read Story
Surgery Before Chemotherapy Is Effective in Ovarian Cancers
Read Story
Why Is Ovarian Cancer Detected So Late?
Read Story
Birth Control Pills May Protect Against Gynecologic Cancers
Read Story
Gynecologic Cancers Not Tied to Higher COVID-19 Death Risk
Read Story
Many Ovarian Tumors May Originate in Two Cell Types
Read Story
New Treatment for Advanced Ovarian Cancer Shows Promise
Read Story
What You Need to Know About Treating Ovarian Cancer
Read Story

Clinical Trials and Research Studies

Phase 2

A Phase 2 Clinical Study of TJ004309 in Combination With Atezolizumab (TECENTRIQ ) in Patients With Advanced or Metastatic Ovarian Cancers and Selected Advanced Solid Tumors

Learn More

Phase 1

A Phase 1b Multicenter Study to Determine the Dose Safety Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.

Learn More

Phase 3

AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs.Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Learn More

Phase 5

A PHASE 1/2 OPEN-LABEL DOSE-ESCALATION SAFETY AND TOLERABILITY STUDY OF NC410 IN SUBJECTS WITH ADVANCED OR METASTATIC SOLID TUMORS

Learn More
View All Related Clinical Trials (11)